Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.
about
Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?Aspirin in the Chemoprevention of Colorectal Neoplasia: An OverviewAspirin with or without an antiemetic for acute migraine headaches in adultsAspirin for in vitro fertilisationAspirin with or without an antiemetic for acute migraine headaches in adultsChuanxiong preparations for preventing strokeLow-dose aspirin for in vitro fertilisationGenome-environment interactions that modulate aging: powerful targets for drug discoveryTime dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approachDoes anybody read "evidence-based" articles?Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trialsChuanxiong preparations for preventing strokeAdverse drug reactions and drug-drug interactions with over-the-counter NSAIDsDrug therapy for prevention of recurrent myocardial infarctionLow-dose aspirin and gastrointestinal hemorrhageIndirect comparison meta-analysis of aspirin therapy after coronary surgeryGuidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapyCardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicityAntiplatelet therapy in cardiovascular diseaseConcomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugsAspirin under fire: aspirin use in the primary prevention of coronary heart diseaseAspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleedingRole of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug usersA critical appraisal of the phenomenon of aspirin resistancePreventable stroke and stroke preventionAspirin use for the prevention of cardiovascular disease: the British Women's Heart and Health StudyAntiplatelet agents for secondary prevention of ischemic strokeAssociation between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studiesPrevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinEndogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptorRisk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseasesThe public health potential of aspirinThe effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosaUpper gastrointestinal bleeding associated with antiplatelet drugsPrimary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national surveyAspirin for the prevention of cardiovascular disease: calculating benefit and harm in the individual patientThe prevalence of risk factors for gastrointestinal complications and use of gastroprotection among persons hospitalized for cardiovascular diseaseTreatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleedingAdverse effects of conventional non-steroidal anti-inflammatory drugs on the upper gastrointestinal tractReview article: gastrointestinal bleeding with low-dose aspirin - what's the risk?
P2860
Q22241777-4D9DCDF9-222E-4A01-97BE-15511934E684Q22306433-B48C69F4-65B4-4A5A-AADE-B5F4A342060BQ24197721-16A5492B-7E2F-4808-BA87-4FAD15342C69Q24235031-B291B5B9-DCBB-417F-A6F2-C26D92D253FDQ24235987-111B66F1-7DB5-48EB-8FA9-80A1819627A3Q24240733-9940303A-F578-4F27-9438-0C2FFBD88277Q24242925-C6A0EB4F-050C-469C-8BFC-66DF576BAFABQ24615803-98EBAFA0-A367-45C2-93FD-3F4C53F69391Q24673561-4D90C078-F528-4519-9DCC-78C8E7D68B38Q24795056-E420B6BF-38A9-40D6-9EC6-33E12B08871DQ24805420-98F5A01E-4B8B-43E2-A3A0-25BA1B414B46Q26471570-0A710806-F10B-44DD-8639-F3755C080A04Q26800279-D3E391EB-2B71-46E1-840F-45F3636E81FCQ28165520-1B3C98DE-2137-4BC4-B5A5-01C99339DED8Q28166154-62DD433A-9853-4461-8F8C-1370F9597913Q28166364-F55D5DFD-3B2A-4CA9-A215-C3958A0429DDQ28166768-1EC106C0-34BF-42D4-B58E-6654158DD98EQ28166985-9E6ABAA8-D0B6-4853-87F6-3E7B35DC387CQ28167737-1171E538-D1E3-415F-AFC5-B568F7ED28A5Q28168123-2716E186-3675-4506-B432-B80D7F908539Q28176243-4776085C-811B-4F6C-8FD7-172DCD4BAB11Q28177240-AF593FFC-360B-4C5B-B014-104367C81CD5Q28182449-071E6C15-E68F-4D43-83DF-32E29C58C66AQ28183919-4D899ED3-3C25-4459-86C4-5FCCD0AD65C4Q28187602-1FBBADEE-7DE4-4914-A39A-340E348D19E3Q28189982-41C9889B-C8B3-4398-9958-B3B3F5649136Q28190669-5FD350A1-337C-4DCC-846D-51F8D66351D5Q28191843-44276E77-B410-43AC-9928-8AA9B94C0297Q28192701-4D2EF49D-4B75-4FF1-88DB-6F59C05A367CQ28193896-D6B76C55-2D42-4152-A945-8EC4C7EE238CQ28193996-4E8C695B-DD2F-44FE-9127-33C2523F6E2FQ28194137-A47BDB2D-3798-4FBB-8C32-E9986B26823DQ28194351-90BCB83B-AD8B-40F4-BEA1-578F487F1F2CQ28194354-BE466CF6-8737-43C4-BAB0-F05AAAC8145DQ28195079-1CA15F2D-58EC-4C13-8592-E731C2AC0623Q28195348-FE4A14E0-DC85-49AB-B112-F580EEF418ECQ28195971-5BAD049C-7729-430A-B793-081C69FD79AFQ28198718-DF887D02-229A-4AD6-A1E5-0D4C27120819Q28199102-3241FDA8-16E2-4B37-A643-3755672E4BD1Q28200403-B2E324FF-57FD-48DE-AE6A-CE27D321353B
P2860
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.
@en
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.
@nl
type
label
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.
@en
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.
@nl
prefLabel
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.
@en
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.
@nl
P2860
P1433
P1476
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.
@en
P2093
P2860
P304
P356
10.1136/BMJ.321.7270.1183
P407
P577
2000-11-01T00:00:00Z